JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2005; 46:756-760, doi:10.1016/j.jacc.2005.05.050 (Published online 24 August 2005).
© 2005 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View Online Appendix
Right arrow All Versions of this Article:
j.jacc.2005.05.050v1
46/5/756    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alfonso, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alfonso, F.

CLINICAL RESEARCH: CLINICAL TRIALS

Long-Term Results (Three to Five Years) of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Stenting (RIBS) Randomized Study

Fernando Alfonso, MD*,*, José M. Augé, MD{dagger},§§, Javier Zueco, MD{ddagger}, Armando Bethencourt, MD§, José R. López-Mínguez, MD||, José M. Hernández, MD, Juan A. Bullones, MD#, Isabel Calvo, MD**, Enrique Esplugas, MD{dagger}{dagger}, María J. Pérez-Vizcayno, MD*, Raul Moreno, MD*, Cristina Fernández, MD*, Rosana Hernández, MD*, Vasco Gama-Ribeiro, MD{ddagger}{ddagger} for the RIBS Investigators

* University Hospital Clinico San Carlos, Madrid, Spain
{dagger} University Hospital Santa Cruz y San Pablo, Barcelona, Spain
{ddagger} University Hospital Marqués de Valdecilla, Santander, Spain
§ University Hospital Son Dureta, Palma de Mallorca, Spain
|| University Hospital Infanta-Cristina, Badajoz, Spain
University Hospital Virgen de la Victoria, Malaga, Spain
# University Hospital Carlos Haya, Malaga, Spain
** University Hospital Miguel Servet, Zaragoza, Spain
{dagger}{dagger} University Hospital Bellvitge, Barcelona, Spain
{ddagger}{ddagger} University Hospital Vila Nova de Gaia, Porto, Portugal
§§ University Hospital Deceased

Manuscript received January 7, 2005; revised manuscript received April 25, 2005, accepted May 9, 2005.

* Reprint requests and correspondence: Dr. Fernando Alfonso, Cardiología Intervencionista, Hospital Universitario "San Carlos," Plaza de Cristo Rey, Madrid 28040, Spain (Email: falf{at}hotmail.com).

OBJECTIVES: We sought to analyze the very late outcomes of patients treated for in-stent restenosis (ISR) according to treatment allocation and 10 prespecified variables.

BACKGROUND: Long-term results (>2 years) of patients with ISR undergoing repeat coronary interventions are not well established.

METHODS: The Restenosis Intrastent: Balloon angioplasty versus elective Stenting (RIBS) randomized study compared these two strategies in 450 patients with ISR. A detailed systematic protocol was used for late clinical follow-up.

RESULTS: At one-year follow-up (100% of patients), the event-free survival was similar in the two groups (77% stent implantation [ST] arm, 71% balloon angioplasty [BA] arm, log-rank p = 0.19). Additional long-term clinical follow-up (median 4.3 years, range 3 to 5 years) was obtained in 98.6% of patients. During this time 22 additional patients died (9 ST arm, 13 BA arm), 7 suffered a myocardial infarction (3 ST arm, 4 BA arm), 23 required coronary surgery (11 ST arm, 12 BA arm), and 9 underwent repeat coronary interventions (4 ST arm, 5 BA arm) (nonexclusive events). At four years the event-free survival was 69% in the ST arm and 64% in the BA arm (log-rank p = 0.21). Among the 10 prespecified variables, vessel size ≥3 mm had a major influence on the clinical outcome at four years, with better results in the ST group (hazard ratio 0.51, 95% confidence interval 0.3 to 0.89, p = 0.016).

CONCLUSIONS: Patients with ISR undergoing repeat interventions have a significant event rate at late follow-up. Continued medical surveillance should be continued after one year. Patients with large vessels have a better outcome after repeat stenting.

Abbreviations and Acronyms
  BA = balloon angioplasty
  ISR = in-stent restenosis
  MI = myocardial infarction
  PCI = percutaneous coronary intervention
  RIBS = Restenosis Intrastent: Balloon angioplasty versus elective Stenting randomized study
  ST = stent implantation




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
P. Garg, D. J. Cohen, T. Gaziano, and L. Mauri
Balancing the Risks of Restenosis and Stent Thrombosis in Bare-Metal Versus Drug-Eluting Stents: Results of a Decision Analytic Model
J. Am. Coll. Cardiol., May 13, 2008; 51(19): 1844 - 1853.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. J. Mishkel, A. L. Moore, S. Markwell, M. C. Shelton, and M. E. Shelton
Long-Term Outcomes After Management of Restenosis or Thrombosis of Drug-Eluting Stents
J. Am. Coll. Cardiol., January 16, 2007; 49(2): 181 - 184.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2005 by the American College of Cardiology Foundation.